American Cannabis Stock Price To Earning
| AMMJ Stock | USD 0.0004 0.0001 33.33% |
American Cannabis fundamentals help investors to digest information that contributes to American Cannabis' financial success or failures. It also enables traders to predict the movement of American Pink Sheet. The fundamental analysis module provides a way to measure American Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to American Cannabis pink sheet.
American |
American Cannabis Company Price To Earning Analysis
American Cannabis' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current American Cannabis Price To Earning | 62.93 X |
Most of American Cannabis' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, American Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, American Cannabis has a Price To Earning of 62 times. This is 217.99% higher than that of the Industrials sector and significantly higher than that of the Consulting Services industry. The price to earning for all United States stocks is 119.12% lower than that of the firm.
American Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses American Cannabis' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of American Cannabis could also be used in its relative valuation, which is a method of valuing American Cannabis by comparing valuation metrics of similar companies.American Cannabis is currently under evaluation in price to earning category among its peers.
American Fundamentals
| Return On Equity | -0.93 | |||
| Return On Asset | -0.23 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 3.49 M | |||
| Shares Outstanding | 85.73 M | |||
| Shares Owned By Insiders | 25.49 % | |||
| Price To Earning | 62.93 X | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 2.43 M | |||
| Gross Profit | 1.06 M | |||
| EBITDA | (1.27 M) | |||
| Net Income | (1.44 M) | |||
| Cash And Equivalents | 873.76 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 806.73 K | |||
| Debt To Equity | 0.49 % | |||
| Current Ratio | 0.48 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (957.92 K) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 1.56 | |||
| Market Capitalization | 2.11 M | |||
| Total Asset | 4.22 M | |||
| Retained Earnings | (4.5 M) | |||
| Working Capital | (162 K) | |||
| Current Asset | 379 K | |||
| Current Liabilities | 541 K | |||
| Z Score | -0.2 | |||
| Net Asset | 4.22 M |
About American Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze American Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of American Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of American Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in American Pink Sheet
American Cannabis financial ratios help investors to determine whether American Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in American with respect to the benefits of owning American Cannabis security.